Noted biotech and pharma analyst Matthew Harrison of Morgan Stanley discusses which companies may be next to bring a promising COVID treatment to market after Merck. Plus, the CEO of coffee giant Illy Cafe weighs in on whether higher commodity prices may need to be passed on to the consumer. And, Erinn Murphy of Piper Sandler reveals the latest results from the firm's "Taking Stock with Teens" survey, including which apparel maker is at the top of teen's spending lists. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
Morning Call